Evaluation and management of lymphoma and leukemia in pregnancy

Clin Obstet Gynecol. 2011 Dec;54(4):556-66. doi: 10.1097/GRF.0b013e318236e68a.

Abstract

Cancer complicates roughly 1 in 1000 pregnancies with roughly 18% of these cases represented by the hematologic malignancies. These can range from an indolent lymphoma requiring only close monitoring to acute, life-threatening, processes requiring emergent therapy, and evaluation for potential termination of the pregnancy. Management of a pregnant woman with a hematologic malignancy requires a multidisciplinary approach combining the expertise of hematologists, obstetricians, and perinatologists to accomplish the best possible outcome. Many women are able to be treated successfully and deliver healthy babies.

Publication types

  • Review

MeSH terms

  • Female
  • Hodgkin Disease / diagnosis
  • Hodgkin Disease / therapy*
  • Humans
  • Leukemia / diagnosis
  • Leukemia / therapy*
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / therapy*
  • Pregnancy
  • Pregnancy Complications, Neoplastic / diagnosis
  • Pregnancy Complications, Neoplastic / therapy*